Use of oral and intraperitoneal BCG in the treatment of malignant melanoma and adenocarcinoma.
D000230:Adenocarcinoma / Q000628:therapy*; D000284:Administration, Oral; D000328:Adult; D000368:Aged; D001500:BCG Vaccine / Q000009:adverse effects; D005260:Female; D005770:Gastrointestinal Neoplasms / Q000628:therapy*; D006801:Humans; D007167:Immunotherapy; D007274:Injections, Intraperitoneal; D008297:Male; D008545:Melanoma / Q000628:therapy*; D008875:Middle Aged; D009163:Mycobacterium bovis; D012882:Skin Tests
D001500:BCG Vaccine